Frantz EyeCare reports 98% of Light Adjustable Lens patients achieved refractive accuracy within ±0.50 D of target, exceeding published national cataract surgery benchmarks.
|Articles|March 7, 2017
What is the Value of Swept Source OCT Technology in Biometry?
Experts discussed the IOLMaster 700 at the ESCRS 2016
Advertisement
Can you benefit from using the IOLMaster 700?
This Swept Source OCT technology generates more accurate scans, increases successful measurements of the eye, and functions seamlessly alongside other Zeiss products. Advancements in the IOLMaster 700 boosts patient satisfaction and improves clinical workflow for surgeons.
Read more to learn about the IOLMaster 700’s versatility, and how this technology produces reliable biometric measurements.
In this e-book, we cover:
· Cataract Penetration Ability of the IOLM aster 700
· Getting indications for macular pathologies
· Efficiency and Workflow
Advertisement
Related to this article
In this Q&A, Ping Moore, OD, covers emerging dry eye therapies, from selenium sulfide to next-gen cyclosporine, and how subtype-guided care shapes treatment choices.
Ophthalmology is projected to face one of the steepest physician shortages of any subspecialty by 2038.
Two investigational pipeline therapies take aim at the root causes of dry eye disease
Dry eye care pivots to root-cause diagnosis and personalized biologics/devices,
Cataract surgery becomes refractive: learn how IOL choices and preop counseling across distance, intermediate and near turn 20/20 into 20/happy.
Findings from the third annual State of Dry Eye survey link symptom management to quality of life gains, including lower anxiety and improved self-confidence.
June brings FDA clearance for Lumvoa, key retina and glaucoma trials, device deals, and hard truths on AI performance in eye care.
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Retinal imaging as a window into atrial fibrillation
2
First patient dosed in phase 3 NPI-001 trial for Usher syndrome RP
3
OCT-980 receives FDA orphan drug designation for retinitis pigmentosa
4
Mediterranean diet linked to slower AMD progression across stages
5